244 related articles for article (PubMed ID: 30341246)
21. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
[TBL] [Abstract][Full Text] [Related]
22. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
23. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
Johansson P; Jeffery J; Al-Ejeh F; Schulz RB; Callen DF; Kumar R; Khanna KK
J Biol Chem; 2014 Jun; 289(26):18514-25. PubMed ID: 24828503
[TBL] [Abstract][Full Text] [Related]
24. SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer.
Yan R; He L; Li Z; Han X; Liang J; Si W; Chen Z; Li L; Xie G; Li W; Wang P; Lei L; Zhang H; Pei F; Cao D; Sun L; Shang Y
Genes Dev; 2015 Mar; 29(6):672-85. PubMed ID: 25792601
[TBL] [Abstract][Full Text] [Related]
25. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
27. Regulation of F-box proteins by noncoding RNAs in human cancers.
Lin M; Xu Y; Gao Y; Pan C; Zhu X; Wang ZW
Cancer Lett; 2019 Dec; 466():61-70. PubMed ID: 31546023
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
29. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Int J Oncol; 2011 Jul; 39(1):155-9. PubMed ID: 21537837
[TBL] [Abstract][Full Text] [Related]
30. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
31. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
34. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
35. Skp1 stabilizes the conformation of F-box proteins.
Yoshida Y; Murakami A; Tanaka K
Biochem Biophys Res Commun; 2011 Jun; 410(1):24-8. PubMed ID: 21640084
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
37. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.
Zhou XL; Zeng D; Ye YH; Sun SM; Lu XF; Liang WQ; Chen CF; Lin HY
Oncol Rep; 2018 Oct; 40(4):1897-1906. PubMed ID: 30066902
[TBL] [Abstract][Full Text] [Related]
39. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of s-phase kinase-associated protein 2 in breast cancer: A meta-analysis.
Shi Y; Li N; Ren H; Guo X; Li Q; Ma S; Wang D
Indian J Cancer; 2015 Dec; 52 Suppl 3():E153-7. PubMed ID: 27453413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
